Traditional EEG application methods using metal electrodes carries several technical challenges that directly affect the wellness of patients. The mandatory detachment of electrodes during CT or MR imaging is one such concern and encumbrance of EEG technologists. Removal and reapplication of these electrodes is time-consuming and can lead to skin breakdown. Witnessing the hardships faced by hospitals to serve their customers, Ives, in 2001, invented the MR conditional electrode system, which can be used effectively during CT or MR imaging, without removing the electrodes from the patient. “Additionally, through persistent engagements with hospitals throughout the world, predominantly in the US, we realized that the healthcare market is heading towards disposable products and we came up with a single-time use product line,” says Patrick Phelan, president of Ives EEG Solutions.
Ives EEG Solution’s disposable MR conditional electrode system helps hospitals to prevent infections that spread through multiple uses of reusable EEG electrodes and save time and money in terms of cross-contamination, excess waste, and valuable technologist’s time.
Focusing specifically on client satisfaction, the company provides significant training and demonstration videos to technologists to help them begin using the product effectively. Ives EEG Solutions was able to successfully eliminate the initial hesitation of the market to accept their innovation through proper engagements with healthcare institutions. The product earned approval from the FDA after extensive testing which proves and certifies that the company’s electrodes would neither harm patients during operation nor affect recording by creating noise.
Ives EEG Solutions is well known in the neurodiagnostic community for pioneering a product that has undeniably changed the lives of thousands of patients nationwide. They continue to strive towards advancing the field by developing new tools and solutions. Ives is currently engaging with a hospital to conduct a 50-patient clinical trial with a new EEG recording product specifically designed to reduce and ultimately eliminate skin breakdown occurrences. The initiative has successfully checked in all operational conditions. Ives EEG Solutions’ new product has also been successfully tested on newborns whose skin is extremely sensitive. Ives’ expert team is in continuous collaboration with hospitals for making necessary modifications to their product line, so they align well with their individual requirements.
Envisaging the future, the company recently partnered with Spes Medica, an Italian entity with rich expertise in all Neurodiagnostic modalities, to effectively address the growing market needs. Under the leadership of Phelan, Ives EEG Solutions and Spes Medica USA expand nationally with increasing scope of its novel product line, worthwhile engagements with its customers, and systematic in-house production. The firm is preparing to roll out several new purpose-built products that can make tremendous changes in the industry. Additionally, the innovation labs of Ives EEG Solutions and Spes Medica are consistently working together towards improving the quality of their numerous solutions while providing their customers with the best tools and resources to diagnose and treat their patients.